Reported Dec 20, 2023 · Terminated
Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore,…
Lupin Pharmaceuticals Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Lupin Pharmaceuticals Inc. · Harborplace Tower · Baltimore, MD · 21202-6174
Is this the product you have?
Penicillamine Tablets USP 250 mg100-count bottleRx Only
- Manufactured forLupin Pharmaceuticals, Inc. Baltimore
- MD 21202 Manufactured byLupin Limited, Nagpur-441 108, India, NDC# 70748-153-01
- Lot codes and dates
Lot # M200498Exp. June 2024
- Amount recalled
- N/A
Why it was recalled
Failed Dissolution Specifications
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Lupin Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.